F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Hepatitis B Surface antigen

1	Differential expression and significance of 5-hydroxymethylcytosine modification in hepatitis B virus carriers and patients with liver cirrhosis and liver cancer 3/27/2023 2:19:30 PM \| Browse: 177 \| Download: 240
2	Chronic hepatitis B: New potential therapeutic drugs target 1/15/2022 7:06:22 AM \| Browse: 274 \| Download: 317
3	Hepatitis B virus persistent infection-related single nucleotide polymorphisms in HLA regions are associated with viral load in hepatoma families 9/29/2021 11:12:00 AM \| Browse: 382 \| Download: 672
4	Global prevalence of hepatitis B virus serological markers among healthcare workers: A systematic review and meta-analysis 9/22/2021 8:09:41 AM \| Browse: 364 \| Download: 486
5	Soluble programmed death-1 is predictive of HBsAg loss in chronic hepatitis B patients after antiviral treatment 7/21/2021 8:24:09 AM \| Browse: 227 \| Download: 488
6	Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach 6/18/2021 5:06:16 AM \| Browse: 281 \| Download: 540
7	Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleoside analogues in hepatitis B e antigen-negative patients 11/24/2020 12:41:22 PM \| Browse: 458 \| Download: 888
8	Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations 9/17/2020 1:56:14 AM \| Browse: 569 \| Download: 1231
9	Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA 9/27/2018 9:38:46 AM \| Browse: 764 \| Download: 883
10	Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy 2/6/2018 3:22:41 AM \| Browse: 983 \| Download: 1326
11	miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma 7/7/2017 11:41:16 AM \| Browse: 1086 \| Download: 926
12	Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors 3/28/2017 10:34:00 AM \| Browse: 982 \| Download: 959
13	Seroprevalence of hepatitis B surface antigen in pregnant women attending antenatal clinic in Honiara Solomon Islands, 2015 12/6/2016 8:33:00 AM \| Browse: 875 \| Download: 1544
14	Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study 11/26/2016 6:56:00 PM \| Browse: 1099 \| Download: 1329
15	Co-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: A randomized trial 5/12/2016 10:38:00 AM \| Browse: 1033 \| Download: 1533
16	Genetic variation of occult hepatitis B virus infection 3/28/2016 3:05:00 PM \| Browse: 982 \| Download: 1245
17	Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma 3/23/2016 4:26:00 PM \| Browse: 1159 \| Download: 1633
18	Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited 3/11/2016 9:54:00 AM \| Browse: 1214 \| Download: 1456
19	Hepatitis B surface antigen levels of cessation of nucleos(t)ide analogs associated with virological relapse in hepatitis B surface antigen-negative chronic hepatitis B patients 7/30/2015 11:19:00 AM \| Browse: 786 \| Download: 1442
20	Seroepidemiology of hepatitis B virus infection and impact of vaccination 7/8/2015 12:00:00 PM \| Browse: 971 \| Download: 1689
21	Induced immunity against hepatitis B virus 6/29/2015 5:40:00 PM \| Browse: 824 \| Download: 1423
22	Applications of human hepatitis B virus preS domain in bio- and nanotechnology 6/29/2015 4:40:00 PM \| Browse: 1160 \| Download: 1536
23	Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification 5/1/2015 7:01:00 PM \| Browse: 1124 \| Download: 1345
24	Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity 2/11/2015 5:56:00 PM \| Browse: 1079 \| Download: 1147
25	Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion 1/18/2015 4:09:00 PM \| Browse: 1046 \| Download: 1062
26	Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt 9/12/2014 8:40:00 PM \| Browse: 957 \| Download: 926
27	HBsAg levels in HBeAg-positive chronic hepatitis B patients with different immune conditions 8/29/2014 11:31:00 AM \| Browse: 875 \| Download: 892
28	Hepatitis B surface antigen seroconversion after HBV reactivation in non-Hodgkin’s lymphoma 8/28/2014 3:52:00 PM \| Browse: 904 \| Download: 945
29	Association between metabolic factors and chronic hepatitis B virus infection 8/26/2014 2:46:00 PM \| Browse: 1034 \| Download: 1033
30	Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues 8/26/2014 1:51:00 PM \| Browse: 839 \| Download: 814
31	Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients 8/26/2014 11:43:00 AM \| Browse: 835 \| Download: 713

Page 1 of 1 ( 31 items )
<<
1
>>

1	Differential expression and significance of 5-hydroxymethylcytosine modification in hepatitis B virus carriers and patients with liver cirrhosis and liver cancer 3/27/2023 2:19:30 PM \| Browse: 177 \| Download: 240
2	Chronic hepatitis B: New potential therapeutic drugs target 1/15/2022 7:06:22 AM \| Browse: 274 \| Download: 317
3	Hepatitis B virus persistent infection-related single nucleotide polymorphisms in HLA regions are associated with viral load in hepatoma families 9/29/2021 11:12:00 AM \| Browse: 382 \| Download: 672
4	Global prevalence of hepatitis B virus serological markers among healthcare workers: A systematic review and meta-analysis 9/22/2021 8:09:41 AM \| Browse: 364 \| Download: 486
5	Soluble programmed death-1 is predictive of HBsAg loss in chronic hepatitis B patients after antiviral treatment 7/21/2021 8:24:09 AM \| Browse: 227 \| Download: 488
6	Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach 6/18/2021 5:06:16 AM \| Browse: 281 \| Download: 540
7	Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleoside analogues in hepatitis B e antigen-negative patients 11/24/2020 12:41:22 PM \| Browse: 458 \| Download: 888
8	Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations 9/17/2020 1:56:14 AM \| Browse: 569 \| Download: 1231
9	Progression and status of antiviral monitoring in patients with chronic hepatitis B: From HBsAg to HBV RNA 9/27/2018 9:38:46 AM \| Browse: 764 \| Download: 883
10	Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy 2/6/2018 3:22:41 AM \| Browse: 983 \| Download: 1326
11	miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma 7/7/2017 11:41:16 AM \| Browse: 1086 \| Download: 926
12	Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors 3/28/2017 10:34:00 AM \| Browse: 982 \| Download: 959
13	Seroprevalence of hepatitis B surface antigen in pregnant women attending antenatal clinic in Honiara Solomon Islands, 2015 12/6/2016 8:33:00 AM \| Browse: 875 \| Download: 1544
14	Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study 11/26/2016 6:56:00 PM \| Browse: 1099 \| Download: 1329
15	Co-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: A randomized trial 5/12/2016 10:38:00 AM \| Browse: 1033 \| Download: 1533
16	Genetic variation of occult hepatitis B virus infection 3/28/2016 3:05:00 PM \| Browse: 982 \| Download: 1245
17	Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma 3/23/2016 4:26:00 PM \| Browse: 1159 \| Download: 1633
18	Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited 3/11/2016 9:54:00 AM \| Browse: 1214 \| Download: 1456
19	Hepatitis B surface antigen levels of cessation of nucleos(t)ide analogs associated with virological relapse in hepatitis B surface antigen-negative chronic hepatitis B patients 7/30/2015 11:19:00 AM \| Browse: 786 \| Download: 1442
20	Seroepidemiology of hepatitis B virus infection and impact of vaccination 7/8/2015 12:00:00 PM \| Browse: 971 \| Download: 1689
21	Induced immunity against hepatitis B virus 6/29/2015 5:40:00 PM \| Browse: 824 \| Download: 1423
22	Applications of human hepatitis B virus preS domain in bio- and nanotechnology 6/29/2015 4:40:00 PM \| Browse: 1160 \| Download: 1536
23	Hepatitis B virus reactivation during immunosuppressive therapy: Appropriate risk stratification 5/1/2015 7:01:00 PM \| Browse: 1124 \| Download: 1345
24	Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity 2/11/2015 5:56:00 PM \| Browse: 1079 \| Download: 1147
25	Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion 1/18/2015 4:09:00 PM \| Browse: 1046 \| Download: 1062
26	Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt 9/12/2014 8:40:00 PM \| Browse: 957 \| Download: 926
27	HBsAg levels in HBeAg-positive chronic hepatitis B patients with different immune conditions 8/29/2014 11:31:00 AM \| Browse: 875 \| Download: 892
28	Hepatitis B surface antigen seroconversion after HBV reactivation in non-Hodgkin’s lymphoma 8/28/2014 3:52:00 PM \| Browse: 904 \| Download: 945
29	Association between metabolic factors and chronic hepatitis B virus infection 8/26/2014 2:46:00 PM \| Browse: 1034 \| Download: 1033
30	Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues 8/26/2014 1:51:00 PM \| Browse: 839 \| Download: 814
31	Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients 8/26/2014 11:43:00 AM \| Browse: 835 \| Download: 713